Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Vantas

(VAN-tus)

A drug used as palliative therapy for advanced prostate cancer. Vantas keeps the testicles from making the male hormone testosterone by blocking other hormones that are needed to make it. This may slow or stop the growth of cancer cells that need testosterone to grow. Vantas contains the active ingredient histrelin acetate. It is a type of LHRH (or GnRH) agonist and a type of androgen deprivation therapy that is reversible.

Vantas

Search NCI's Dictionary of Cancer Terms